Skip to main content

TNR Still's Now Journal Club - Pivotal Trials in SJIA & AOSD Approved Meds

Jul 27, 2022 7:54 am
This week's Stills disease Journal Club features expert discussants Drs. Olga Petryna, Daniel Lovell, Hermine Brunner and Jack Cush. Journal articles reviewed includes: - CONSIDER Trial. Canakinumab for Treatment of Adult-Onset Still's Disease. Kedor C. Ann Rheum Dis 2020 Aug;79:1090-1097 - TENDER Trial. Tocilizumab in systemic juvenile idiopathic arthritis. De Benedetti F. N Engl J Med. 2012 Dec 20;367:2385-95


If you are a health practitioner, you may to comment.

Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.